Why this course is different from every other AI training a pharma executive has encountered
The pharmaceutical executives who get the most value from this course are not those who know the least about AI — they are those who have attended generic AI training elsewhere and found it impossible to apply to their actual work.
This course is built differently. Every concept is introduced through a pharmaceutical lens. Every example is drawn from real pharma commercial situations. Every framework is designed to be applied to the specific decisions a pharma executive makes — in drug development, regulatory affairs, medical affairs, market access, and commercial operations.
There is no coding. There is no data science theory. There is no content that requires translation into a pharma context before it becomes useful — because it was built inside that context from the beginning.
What the 12 modules cover — and what you will be able to do after each one
The course covers twelve modules — moving from AI foundations through to strategic application and future preparedness. Each module is designed to be immediately applicable to pharmaceutical commercial reality rather than requiring translation from a generic business context:
Module 1: AI fundamentals for non-technical professionals
Module 1: AI fundamentals for non-technical professionals A clear, jargon-free introduction to artificial intelligence and machine learning — what they are, how they work, and why the distinction between different types of AI matters for pharmaceutical applications.
Module 2: Generative AI in pharma — what it is and how to use it compliantly
A practical introduction to Generative AI — including large language models like ChatGPT — covering how they work, where they create genuine value in pharmaceutical contexts, and the compliance and regulatory considerations that govern their use in this industry.
Module 3: Why strategic AI matters — and what happens when it is not strategic
The difference between AI that delivers commercial results and AI that produces impressive pilots with no measurable impact. This module establishes the strategic framework that runs through every subsequent module — connecting AI capability to business outcome.
Module 4: AI across the pharma value chain — discovery through regulatory
How AI is being applied in drug discovery, R&D, clinical trials, medical affairs, and regulatory affairs — with specific examples from each function and a clear view of where the most significant efficiency and quality gains are being achieved.
Module 5: AI in market access, sales and marketing
Specific AI applications for market access strategy, HCP targeting, promotional personalisation, and commercial performance optimisation — with real examples of how leading pharmaceutical organisations are applying AI to accelerate revenue and improve market access outcomes.
Module 6: AI compliance, legal, and ethics in pharmaceutical organisations
The regulatory, legal, and ethical requirements that govern AI use in pharma — including privacy regulations, promotional compliance, data governance, and the specific considerations that make pharmaceutical AI compliance more complex than in most other industries.
Module 7: How pharmaceutical AI projects actually work
The real structure of an AI project — from strategic brief through data assessment, model development, pilot, and deployment — with a clear view of where projects most commonly fail and what the success factors actually are.
Module 8: Why most pharma AI implementations fail — and how to ensure yours does not
The specific organisational, strategic, and technical reasons behind the 85% AI project failure rate — and the practical steps that consistently differentiate successful implementations from expensive pilots that go nowhere.
Module 9: Where to begin — your first 90 days with AI in pharma
A practical starting framework for pharma executives who leave this course ready to act — covering how to identify your highest-value AI opportunity, how to build the business case, and how to sequence your first initiatives for maximum impact and minimum risk.
Module 10: The AI tools most relevant to pharma professionals — available now
A curated guide to the AI tools with the most practical value for pharmaceutical commercial, medical, and regulatory work — including free and low-cost options that can be adopted immediately, and an assessment of which tools are compliant within pharma’s regulatory environment.
Module 11: Embedding AI in your organisation and your role
How to introduce AI capability into your specific organisational context — covering change management, stakeholder alignment, common misconceptions that derail AI adoption, and how to build the internal case for AI investment at leadership level.
Module 12: The AI horizon — what is coming in pharma AI and how to prepare
The most significant AI developments on the horizon for pharmaceutical organisations — including emerging capabilities in drug discovery, regulatory AI, and commercial operations — and a practical framework for staying ahead of a landscape that is evolving faster than most organisations can track.
What you will leave this course able to do
By the end of this course you will have a complete working understanding of how AI applies to every function of the pharmaceutical value chain — and a clear framework for identifying, prioritising, and beginning to execute the AI initiatives most relevant to your specific role and organisation.
Specifically, completing this course will enable you to:
- Speak confidently about AI in leadership and board conversations — with the language, frameworks, and commercial grounding to be taken seriously
- Identify the highest-value AI opportunities in your specific function — whether that is commercial, medical affairs, market access, regulatory, or R&D — and make a credible business case for pursuing them
- Evaluate AI vendors, tools, and proposals from a position of informed judgement rather than having to defer entirely to technical teams
- Understand what makes AI projects succeed and fail in pharmaceutical organisations — and how to structure your initiatives to be in the minority that deliver
- Navigate AI compliance and governance requirements in pharma without being paralysed by regulatory uncertainty
- Build a practical 90-day AI action plan for your role — leaving the course with a concrete starting point rather than a general sense of possibility
Who this course is designed for
This course is designed for pharmaceutical professionals across all functions and seniority levels who need a rigorous, pharma-specific understanding of AI — without coding, data science prerequisites, or content that requires translation from another industry before it becomes relevant.
It is particularly well suited for:
- Senior commercial, medical, market access, and regulatory leaders who need to lead AI conversations with confidence — commissioning the right work, challenging assumptions, and making informed investment decisions
- Brand directors, business unit leaders, and team managers who are accountable for results in an environment where AI is increasingly shaping competitive dynamics
- Professionals who have attended generic AI training and found it too technical, too basic, or too disconnected from the pharmaceutical context to be useful
Executives preparing for internal AI strategy conversations, board presentations, or vendor evaluations who need a credible, commercially grounded foundation
Start building your pharmaceutical AI capability today
This course gives you immediate, lifetime access to all 12 modules — completable at your own pace, in sessions that fit around your existing commitments. Most participants complete the full course within one to two weeks and report being able to apply what they have learned from the first module onwards.
Investment: US$997 — includes all course materials, lifetime access, and any future updates to course content.
Other courses you may like
Complete Training in AI for Pharma Execs (On-line training)
When it comes to courses on AI, the market is saturated with content that is either too techie, or too basic, generic, outdated, and not even relatable to pharmaceuticals – at all!
Luckily, Eularis, a company dedicated to leveraging AI in Pharma has already worked out a solution to this problem.